1. Home
  2. KNRX vs ESLA Comparison

KNRX vs ESLA Comparison

Compare KNRX & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$1.23

Market Cap

50.5M

Sector

Technology

ML Signal

N/A

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$0.93

Market Cap

48.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNRX
ESLA
Founded
2009
2021
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.5M
48.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
KNRX
ESLA
Price
$1.23
$0.93
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
31.2K
76.4K
Earning Date
06-12-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,149,328.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$0.73
52 Week High
$4.00
$3.15

Technical Indicators

Market Signals
Indicator
KNRX
ESLA
Relative Strength Index (RSI) N/A 34.96
Support Level N/A $0.93
Resistance Level N/A $1.17
Average True Range (ATR) 0.00 0.17
MACD 0.00 -0.02
Stochastic Oscillator 0.00 12.47

Price Performance

Historical Comparison
KNRX
ESLA

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: